Logo image of LRCX

LAM RESEARCH CORP (LRCX) Stock Fundamental Analysis

USA - NASDAQ:LRCX - US5128073062 - Common Stock

144.78 USD
+6.47 (+4.68%)
Last: 10/15/2025, 8:00:00 PM
146.5 USD
+1.72 (+1.19%)
Pre-Market: 10/16/2025, 8:36:44 AM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LRCX. LRCX was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. LRCX scores excellent on profitability, but there are some minor concerns on its financial health. LRCX is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make LRCX suitable for growth investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

LRCX had positive earnings in the past year.
In the past year LRCX had a positive cash flow from operations.
Each year in the past 5 years LRCX has been profitable.
LRCX had a positive operating cash flow in each of the past 5 years.
LRCX Yearly Net Income VS EBIT VS OCF VS FCFLRCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

LRCX has a Return On Assets of 25.10%. This is amongst the best in the industry. LRCX outperforms 96.43% of its industry peers.
The Return On Equity of LRCX (54.33%) is better than 95.54% of its industry peers.
With an excellent Return On Invested Capital value of 35.49%, LRCX belongs to the best of the industry, outperforming 98.21% of the companies in the same industry.
LRCX had an Average Return On Invested Capital over the past 3 years of 31.47%. This is significantly above the industry average of 10.94%.
The 3 year average ROIC (31.47%) for LRCX is below the current ROIC(35.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 25.1%
ROE 54.33%
ROIC 35.49%
ROA(3y)23.18%
ROA(5y)24.18%
ROE(3y)51.37%
ROE(5y)58.46%
ROIC(3y)31.47%
ROIC(5y)32.89%
LRCX Yearly ROA, ROE, ROICLRCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

LRCX has a better Profit Margin (29.06%) than 89.29% of its industry peers.
In the last couple of years the Profit Margin of LRCX has grown nicely.
LRCX's Operating Margin of 32.01% is amongst the best of the industry. LRCX outperforms 91.96% of its industry peers.
In the last couple of years the Operating Margin of LRCX has grown nicely.
With a decent Gross Margin value of 48.70%, LRCX is doing good in the industry, outperforming 60.71% of the companies in the same industry.
LRCX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 32.01%
PM (TTM) 29.06%
GM 48.71%
OM growth 3Y0.81%
OM growth 5Y3.76%
PM growth 3Y2.83%
PM growth 5Y5.33%
GM growth 3Y2.15%
GM growth 5Y1.2%
LRCX Yearly Profit, Operating, Gross MarginsLRCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LRCX is creating value.
Compared to 1 year ago, LRCX has less shares outstanding
The number of shares outstanding for LRCX has been reduced compared to 5 years ago.
LRCX has a better debt/assets ratio than last year.
LRCX Yearly Shares OutstandingLRCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
LRCX Yearly Total Debt VS Total AssetsLRCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

The Debt to FCF ratio of LRCX is 0.83, which is an excellent value as it means it would take LRCX, only 0.83 years of fcf income to pay off all of its debts.
LRCX's Debt to FCF ratio of 0.83 is fine compared to the rest of the industry. LRCX outperforms 76.79% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that LRCX is not too dependend on debt financing.
LRCX has a Debt to Equity ratio of 0.38. This is in the lower half of the industry: LRCX underperforms 65.18% of its industry peers.
Even though the debt/equity ratio score it not favorable for LRCX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.83
Altman-Z N/A
ROIC/WACC3.07
WACC11.54%
LRCX Yearly LT Debt VS Equity VS FCFLRCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

LRCX has a Current Ratio of 2.21. This indicates that LRCX is financially healthy and has no problem in meeting its short term obligations.
LRCX has a Current ratio of 2.21. This is in the lower half of the industry: LRCX underperforms 68.75% of its industry peers.
A Quick Ratio of 1.55 indicates that LRCX should not have too much problems paying its short term obligations.
The Quick ratio of LRCX (1.55) is worse than 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.55
LRCX Yearly Current Assets VS Current LiabilitesLRCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.63% over the past year.
Measured over the past years, LRCX shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.02% on average per year.
LRCX shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.68%.
The Revenue has been growing by 12.91% on average over the past years. This is quite good.
EPS 1Y (TTM)36.63%
EPS 3Y7.72%
EPS 5Y21.02%
EPS Q2Q%63.39%
Revenue 1Y (TTM)23.68%
Revenue growth 3Y2.29%
Revenue growth 5Y12.91%
Sales Q2Q%33.58%

3.2 Future

LRCX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.67% yearly.
The Revenue is expected to grow by 8.28% on average over the next years. This is quite good.
EPS Next Y10.59%
EPS Next 2Y12.33%
EPS Next 3Y13.55%
EPS Next 5Y16.67%
Revenue Next Year10.04%
Revenue Next 2Y10%
Revenue Next 3Y9.65%
Revenue Next 5Y8.28%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LRCX Yearly Revenue VS EstimatesLRCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
LRCX Yearly EPS VS EstimatesLRCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.97, LRCX can be considered very expensive at the moment.
Based on the Price/Earnings ratio, LRCX is valued a bit cheaper than the industry average as 70.54% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of LRCX to the average of the S&P500 Index (27.53), we can say LRCX is valued slightly more expensively.
A Price/Forward Earnings ratio of 31.62 indicates a quite expensive valuation of LRCX.
LRCX's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.04, LRCX is valued a bit more expensive.
Industry RankSector Rank
PE 34.97
Fwd PE 31.62
LRCX Price Earnings VS Forward Price EarningsLRCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

LRCX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LRCX is cheaper than 65.18% of the companies in the same industry.
75.89% of the companies in the same industry are more expensive than LRCX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 33.81
EV/EBITDA 28.74
LRCX Per share dataLRCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LRCX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of LRCX may justify a higher PE ratio.
A more expensive valuation may be justified as LRCX's earnings are expected to grow with 13.55% in the coming years.
PEG (NY)3.3
PEG (5Y)1.66
EPS Next 2Y12.33%
EPS Next 3Y13.55%

6

5. Dividend

5.1 Amount

LRCX has a yearly dividend return of 0.74%, which is pretty low.
Compared to an average industry Dividend Yield of 2.15, LRCX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, LRCX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

The dividend of LRCX is nicely growing with an annual growth rate of 14.54%!
LRCX has been paying a dividend for at least 10 years, so it has a reliable track record.
LRCX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)14.54%
Div Incr Years10
Div Non Decr Years10
LRCX Yearly Dividends per shareLRCX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

LRCX pays out 21.45% of its income as dividend. This is a sustainable payout ratio.
The dividend of LRCX is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP21.45%
EPS Next 2Y12.33%
EPS Next 3Y13.55%
LRCX Yearly Income VS Free CF VS DividendLRCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
LRCX Dividend Payout.LRCX Dividend Payout, showing the Payout Ratio.LRCX Dividend Payout.PayoutRetained Earnings

LAM RESEARCH CORP

NASDAQ:LRCX (10/15/2025, 8:00:00 PM)

Premarket: 146.5 +1.72 (+1.19%)

144.78

+6.47 (+4.68%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners89.15%
Inst Owner Change0.2%
Ins Owners0.26%
Ins Owner Change-0.14%
Market Cap182.57B
Analysts80
Price Target118.66 (-18.04%)
Short Float %2.47%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Yearly Dividend0.89
Dividend Growth(5Y)14.54%
DP21.45%
Div Incr Years10
Div Non Decr Years10
Ex-Date09-24 2025-09-24 (0.26)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.6%
Min EPS beat(2)1.42%
Max EPS beat(2)7.79%
EPS beat(4)4
Avg EPS beat(4)3.92%
Min EPS beat(4)1.42%
Max EPS beat(4)7.79%
EPS beat(8)8
Avg EPS beat(8)4.87%
EPS beat(12)12
Avg EPS beat(12)5.99%
EPS beat(16)13
Avg EPS beat(16)5.29%
Revenue beat(2)1
Avg Revenue beat(2)0.41%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)0.3%
Min Revenue beat(4)-0.48%
Max Revenue beat(4)1.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)6
Avg Revenue beat(12)0.21%
Revenue beat(16)7
Avg Revenue beat(16)-0.27%
PT rev (1m)6.1%
PT rev (3m)24.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22.15%
EPS NY rev (1m)0.47%
EPS NY rev (3m)10.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.62%
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)7.03%
Valuation
Industry RankSector Rank
PE 34.97
Fwd PE 31.62
P/S 9.9
P/FCF 33.81
P/OCF 29.64
P/B 18.51
P/tB 22.67
EV/EBITDA 28.74
EPS(TTM)4.14
EY2.86%
EPS(NY)4.58
Fwd EY3.16%
FCF(TTM)4.28
FCFY2.96%
OCF(TTM)4.88
OCFY3.37%
SpS14.62
BVpS7.82
TBVpS6.39
PEG (NY)3.3
PEG (5Y)1.66
Profitability
Industry RankSector Rank
ROA 25.1%
ROE 54.33%
ROCE 39.93%
ROIC 35.49%
ROICexc 62.53%
ROICexgc 79.72%
OM 32.01%
PM (TTM) 29.06%
GM 48.71%
FCFM 29.29%
ROA(3y)23.18%
ROA(5y)24.18%
ROE(3y)51.37%
ROE(5y)58.46%
ROIC(3y)31.47%
ROIC(5y)32.89%
ROICexc(3y)52.82%
ROICexc(5y)54.36%
ROICexgc(3y)66.54%
ROICexgc(5y)68.82%
ROCE(3y)35.41%
ROCE(5y)37.02%
ROICexcg growth 3Y7.04%
ROICexcg growth 5Y0.35%
ROICexc growth 3Y5.47%
ROICexc growth 5Y4.28%
OM growth 3Y0.81%
OM growth 5Y3.76%
PM growth 3Y2.83%
PM growth 5Y5.33%
GM growth 3Y2.15%
GM growth 5Y1.2%
F-Score8
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.83
Debt/EBITDA 0.59
Cap/Depr 196.54%
Cap/Sales 4.12%
Interest Coverage 250
Cash Conversion 97.97%
Profit Quality 100.79%
Current Ratio 2.21
Quick Ratio 1.55
Altman-Z N/A
F-Score8
WACC11.54%
ROIC/WACC3.07
Cap/Depr(3y)151.1%
Cap/Depr(5y)146.11%
Cap/Sales(3y)3.22%
Cap/Sales(5y)3.04%
Profit Quality(3y)105.22%
Profit Quality(5y)90.8%
High Growth Momentum
Growth
EPS 1Y (TTM)36.63%
EPS 3Y7.72%
EPS 5Y21.02%
EPS Q2Q%63.39%
EPS Next Y10.59%
EPS Next 2Y12.33%
EPS Next 3Y13.55%
EPS Next 5Y16.67%
Revenue 1Y (TTM)23.68%
Revenue growth 3Y2.29%
Revenue growth 5Y12.91%
Sales Q2Q%33.58%
Revenue Next Year10.04%
Revenue Next 2Y10%
Revenue Next 3Y9.65%
Revenue Next 5Y8.28%
EBIT growth 1Y36.42%
EBIT growth 3Y3.12%
EBIT growth 5Y17.15%
EBIT Next Year16.89%
EBIT Next 3Y13.89%
EBIT Next 5Y10.27%
FCF growth 1Y26.9%
FCF growth 3Y28.36%
FCF growth 5Y22.94%
OCF growth 1Y32.4%
OCF growth 3Y25.72%
OCF growth 5Y23.7%